Note 3 - Contingencies and Uncertainties

6 Months Ended

Jun. 30, 2017

Notes to Financial Statements

Contingencies Disclosure [Text Block]

NOTE

3

– CONTINGENCIES AND UNCERTAINTIES

On

March 11, 2015,

the Company’s application under the MMPR for a license to produce marijuana for medical purposes was formally rejected by Health Canada. The Company filed an application for judicial review in Canadian federal court on

April 10, 2015

in order to obtain a reversal of this decision.

We discontinued this action in

February 2016.

CEN continues to pursue relief and damages and on or about

February 2, 2016,

filed a Statement of Claim against the Attorney General

of Canada in the

Ontario

Superior Court of

Justice, for

$15

million and other damages and relief.

This case is in the discovery phase. We cannot provide any assurances as to the timing or decision or outcome related to our action seeking damages.